BIOPHARMA SOLUTIONS

Valuable Insights – Cell by Cell, From Translational Research to Launch
Our clinical solutions, proven by partnerships, help enhance drug development and expedite commercialization with valuable insights into the dynamics of cancer growth and evolution. Comprehensive Cancer Profiling combines our proven and proprietary CTC capabilities, along with ctDNA and immune-cell analysis to create a more complete picture for discovering new insights into the dynamics of cancer growth. We use our insights to develop clinical solutions that enhance drug development for proven clinical utility.

PROCESS

PHASE I/IB

  • Biomarker verification
  • Novel PD marker development
  • Target and marker prevalence in larger cohorts
  • Efficacy analysis

PHASE II

  • Retrospective studies for marker efficacy
  • Prospective patient selection
  • Clinical analysis comparing marker efficacy vs. established endpoints
  • Identification of resistance signatures
  • CDx Development

PHASE III

  • LDT to PMA
  • Prospective analysis and CDx development
  • Regulatory support

GLOBAL CAPABILITIES

AREAS OF FOCUS

breast

prostate

IMMUNO-ONCOLOGY (IO)

lung caNCER